Literature DB >> 24702539

Toward the identification of peripheral epigenetic biomarkers of schizophrenia.

A Guidotti1, J Auta, J M Davis, E Dong, D P Gavin, D R Grayson, R P Sharma, R C Smith, P Tueting, A Zhubi.   

Abstract

Schizophrenia (SZ) is a heritable, nonmendelian, neurodevelopmental disorder in which epigenetic dysregulation of the brain genome plays a fundamental role in mediating the clinical manifestations and course of the disease. The authors recently reported that two enzymes that belong to the dynamic DNA methylation/demethylation network-DNMT (DNA methyltransferase) and TET (ten-eleven translocase; 5-hydroxycytosine translocator)-are abnormally increased in corticolimbic structures of SZ postmortem brain, suggesting a causal relationship between clinical manifestations of SZ and changes in DNA methylation and in the expression of SZ candidate genes (e.g., brain-derived neurotrophic factor [BDNF], glucocorticoid receptor [GCR], glutamic acid decarboxylase 67 [GAD67], reelin). Because the clinical manifestations of SZ typically begin with a prodrome followed by a first episode in adolescence with subsequent deterioration, it is obvious that the natural history of this disease cannot be studied only in postmortem brain. Hence, the focus is currently shifting towards the feasibility of studying epigenetic molecular signatures of SZ in blood cells. Initial studies show a significant enrichment of epigenetic changes in lymphocytes in gene networks directly relevant to psychiatric disorders. Furthermore, the expression of DNA-methylating/demethylating enzymes and SZ candidate genes such as BDNF and GCR are altered in the same direction in both brain and blood lymphocytes. The coincidence of these changes in lymphocytes and brain supports the hypothesis that common environmental or genetic risk factors are operative in altering the epigenetic components involved in orchestrating transcription of specific genes in brain and peripheral tissues. The identification of DNA methylation signatures for SZ in peripheral blood cells of subjects with genetic and clinical high risk would clearly have potential for the diagnosis of SZ early in its course and would be invaluable for initiating early intervention and individualized treatment plans.

Entities:  

Keywords:  DNA methylation; brain-derived nerve growth factor; glucocorticoid receptor; lymphocytes

Mesh:

Substances:

Year:  2014        PMID: 24702539      PMCID: PMC4112595          DOI: 10.3109/01677063.2014.892485

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  88 in total

1.  Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.

Authors:  M J Webster; M B Knable; J O'Grady; J Orthmann; C S Weickert
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

Review 2.  Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

Authors:  Diana O Perkins; Hongbin Gu; Kalina Boteva; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

3.  TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity.

Authors:  Kristine Williams; Jesper Christensen; Marianne Terndrup Pedersen; Jens V Johansen; Paul A C Cloos; Juri Rappsilber; Kristian Helin
Journal:  Nature       Date:  2011-04-13       Impact factor: 49.962

4.  TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior.

Authors:  Simona Keller; Marco Sarchiapone; Federica Zarrilli; Rossella Tomaiuolo; Vladimir Carli; Tiziana Angrisano; Alja Videtic; Felice Amato; Raffaela Pero; Massimo di Giannantonio; Miriam Iosue; Francesca Lembo; Giuseppe Castaldo; Lorenzo Chiariotti
Journal:  J Affect Disord       Date:  2011-07-29       Impact factor: 4.839

5.  Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide completers with a history of childhood abuse.

Authors:  Benoit Labonte; Volodymyr Yerko; Jeffrey Gross; Naguib Mechawar; Michael J Meaney; Moshe Szyf; Gustavo Turecki
Journal:  Biol Psychiatry       Date:  2012-03-22       Impact factor: 13.382

6.  Increased stress-induced dopamine release in psychosis.

Authors:  Romina Mizrahi; Jean Addington; Pablo M Rusjan; Ivonne Suridjan; Alvina Ng; Isabelle Boileau; Jens C Pruessner; Gary Remington; Sylvain Houle; Alan A Wilson
Journal:  Biol Psychiatry       Date:  2011-11-30       Impact factor: 13.382

7.  Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming.

Authors:  Hugh D Morgan; Wendy Dean; Heather A Coker; Wolf Reik; Svend K Petersen-Mahrt
Journal:  J Biol Chem       Date:  2004-09-24       Impact factor: 5.157

8.  Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia.

Authors:  Kayla A Chase; David P Gavin; Alessandro Guidotti; Rajiv P Sharma
Journal:  Schizophr Res       Date:  2013-06-28       Impact factor: 4.939

9.  Methylation patterns in whole blood correlate with symptoms in schizophrenia patients.

Authors:  Jingyu Liu; Jiayu Chen; Stefan Ehrlich; Esther Walton; Tonya White; Nora Perrone-Bizzozero; Juan Bustillo; Jessica A Turner; Vince D Calhoun
Journal:  Schizophr Bull       Date:  2013-06-03       Impact factor: 9.306

10.  Epigenetic predictor of age.

Authors:  Sven Bocklandt; Wen Lin; Mary E Sehl; Francisco J Sánchez; Janet S Sinsheimer; Steve Horvath; Eric Vilain
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

View more
  18 in total

1.  Exploring the genetic underpinnings of brain and behavioral disorders.

Authors:  Wei-Dong Yao; Chun-Fang Wu
Journal:  J Neurogenet       Date:  2014 Mar-Jun       Impact factor: 1.250

2.  Risperidone effects on heterochromatin: the role of kinase signaling.

Authors:  B Feiner; K A Chase; J K Melbourne; C Rosen; R P Sharma
Journal:  Clin Exp Immunol       Date:  2019-02-03       Impact factor: 4.330

Review 3.  Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics.

Authors:  Chi-Yu Lai; Elizabeth Scarr; Madhara Udawela; Ian Everall; Wei J Chen; Brian Dean
Journal:  World J Psychiatry       Date:  2016-03-22

Review 4.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

5.  Changes in DNA methylation over the growing season differ between North Carolina farmworkers and non-farmworkers.

Authors:  Timothy D Howard; Fang-Chi Hsu; Haiying Chen; Sara A Quandt; Jennifer W Talton; Phillip Summers; Thomas A Arcury
Journal:  Int Arch Occup Environ Health       Date:  2016-06-27       Impact factor: 3.015

6.  Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder.

Authors:  Joanne H Huang; Shaunna S Berkovitch; Jonathan Iaconelli; Bradley Watmuff; Hyoungjun Park; Shrikanta Chattopadhyay; Donna McPhie; Dost Öngür; Bruce M Cohen; Clary B Clish; Rakesh Karmacharya
Journal:  Mol Neuropsychiatry       Date:  2016-06-24

Review 7.  Epigenetic mechanisms in schizophrenia.

Authors:  Kimberly R Shorter; Brooke H Miller
Journal:  Prog Biophys Mol Biol       Date:  2015-05-07       Impact factor: 3.667

8.  DNA extracted from saliva for methylation studies of psychiatric traits: evidence tissue specificity and relatedness to brain.

Authors:  Alicia K Smith; Varun Kilaru; Torsten Klengel; Kristina B Mercer; Bekh Bradley; Karen N Conneely; Kerry J Ressler; Elisabeth B Binder
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-10-29       Impact factor: 3.568

9.  Taking a chance on epigenetics.

Authors:  Sophie A Lelièvre
Journal:  Front Genet       Date:  2014-07-04       Impact factor: 4.599

10.  Differential methylation at the RELN gene promoter in temporal cortex from autistic and typically developing post-puberal subjects.

Authors:  Carla Lintas; Roberto Sacco; Antonio M Persico
Journal:  J Neurodev Disord       Date:  2016-04-29       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.